Efficacy and safety of AM-111 in the Treatment of Acute Inner Ear Hearing Loss.
Phase of Trial: Phase III
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Brimapitide (Primary)
- Indications Sensorineural hearing loss
- Focus Registrational; Therapeutic Use
- Acronyms HEALOS
- Sponsors Auris Medical
- 04 Jan 2018 Pooled results from this and a phase II trial, published in an Auris Medical media release.
- 04 Jan 2018 Results of post hoc analysis published in an Auris Medical media release.
- 28 Nov 2017 Top-line results presented in an Auris Medical media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History